GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaCielo Ltd (OTCPK:PCLOF) » Definitions » Total Liabilities

PCLOF (PharmaCielo) Total Liabilities : $18.19 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is PharmaCielo Total Liabilities?

PharmaCielo's Total Liabilities for the quarter that ended in Dec. 2024 was $18.19 Mil.

PharmaCielo's quarterly Total Liabilities increased from Jun. 2024 ($18.94 Mil) to Sep. 2024 ($20.16 Mil) but then declined from Sep. 2024 ($20.16 Mil) to Dec. 2024 ($18.19 Mil).

PharmaCielo's annual Total Liabilities increased from Dec. 2022 ($13.78 Mil) to Dec. 2023 ($17.87 Mil) and increased from Dec. 2023 ($17.87 Mil) to Dec. 2024 ($18.19 Mil).


PharmaCielo Total Liabilities Historical Data

The historical data trend for PharmaCielo's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCielo Total Liabilities Chart

PharmaCielo Annual Data
Trend Aug17 Aug18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial 13.88 12.99 13.78 17.87 18.19

PharmaCielo Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.87 18.82 18.94 20.16 18.19

PharmaCielo Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

PharmaCielo's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=14.903+(3.283+-4.4408920985006E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=18.19

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=12.91--5.275
=18.19

PharmaCielo's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=14.903+(3.283+-4.4408920985006E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=18.19

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=12.91--5.275
=18.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaCielo Total Liabilities Related Terms

Thank you for viewing the detailed overview of PharmaCielo's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaCielo Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of its revenue in the form of the Sale of Cannabis derivative products in Colombia.

PharmaCielo Headlines

From GuruFocus